 |
市場調查報告書
商品編碼
1674127
腎臟病診斷市場（按檢測類型、產品類型、最終用戶和地區分類）Preeclampsia Diagnostics Market, By Test Type, By Product Type, By End User, By Geography |
||||||
價格
簡介目錄
2025 年全球腎臟病診斷市場規模估計為 23.2 億美元，預計到 2032 年將達到 46 億美元，2025 年至 2032 年的複合年成長率為 10.3%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 23.2億美元 |
| 效能資料 | 從2020年到2024年 | 預測期 | 2025年至2032年 |
| 預測期：2025-2032年複合年成長率： | 10.30% | 2032年價值預測 | 46億美元 |
數字。 2025 年腎臟病診斷市場佔有率（%）（按地區分類）
腎臟病症是一種妊娠併發症，其特徵是妊娠 20 週後出現高血壓和尿液中出現蛋白質。如果未被發現，對母親和胎兒都可能造成危險。早期診斷至關重要，這樣臨床醫生就可以密切監測病情，並在腎臟病惡化時分娩嬰兒。傳統的診斷方法依賴臨床症狀和體徵，具有局限性。隨著人們對子癇前症的認知不斷提高，全球腎臟病診斷市場可能會持續成長。已經開發並採用了多種新的診斷工具來篩檢有風險的女性並及時發現疾病。
市場動態：
全球腎臟病診斷市場的成長是由全球腎臟病的不斷上升所推動的。根據最近的估計，全球整體約有 5-8% 的懷孕會罹患腎臟病。初次生育的母親年齡不斷增加也是導致病例增加的原因之一。新產品的推出和早期篩檢先進診斷技術的日益普及為市場成長提供了機會。然而，低收入地區對腎臟病的認知不足和缺乏全民健康覆蓋可能會阻礙市場成長。新診斷設備的高成本可能是一個挑戰，尤其是在對價格敏感的新興市場。
本研究的主要特點
- 本報告對全球腎臟病診斷市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
- 它還強調了各個領域的潛在商機，並解釋了該市場的引人注目的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
- 本報告根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，概述了全球腎臟病診斷市場的主要企業。
- 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
- 全球腎臟病診斷市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 可以透過分析全球腎臟病診斷市場中使用的各種策略矩陣來促進相關人員的決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管情景
- 收購與合作場景
- 資金籌措與投資
- PEST分析
- 波特的分析
4. 全球腎臟病診斷市場-冠狀病毒（COVID-19）大流行的影響
- 整體影響
- 政府舉措
- COVID-19 市場影響
5. 2020-2032 年全球腎臟病診斷市場（按檢測類型分類）（十億美元）
- 血液檢查
- 尿液檢查
- 其他
6. 2020-2032 年全球腎臟病診斷市場（按產品類型分類）（十億美元）
- 裝置
- 耗材
7. 2020-2032 年全球腎臟病診斷市場（按最終用戶分類）（十億美元）
- 醫院
- 專科診所
- 診斷中心
- 其他
8. 2020-2032 年全球腎臟病診斷市場（按地區分類）（十億美元）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第9章競爭格局
- 公司簡介
- Roche Diagnostic
- Thermo Fisher Giving Inc.
- PerkinElmer
- Siemens Healthineers
- Abbott Laboratories
- Beckman Coulter
- Becton, Dickinson and Company（BD）
- bioMerieux
- F. Hoffmann-La Roche Ltd
- Metabolomic Diagnostics Ltd
- Diabetomics, Inc.
- Quidel Corporation
- Sera Prognostics
- Brahms GmbH
- The Progenix Group
第 10 章分析師建議
- 機會
- 分析師觀點
- Coherent Opportunity Map
第 11 章參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI4606
Global Preeclampsia Diagnostics Market is estimated to be valued at USD 2.32 Bn in 2025 and is expected to reach USD 4.60 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.32 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 10.30% | 2032 Value Projection: | USD 4.60 Bn |
Figure. Preeclampsia Diagnostics Market Share (%), By Region 2025
Preeclampsia is a pregnancy complication characterized by high blood pressure and presence of protein in the urine after 20 weeks of gestation. It can be a dangerous condition for both mother and baby, if undetected. Early diagnosis is crucial to allow clinicians to closely monitor the condition and deliver the baby if preeclampsia worsens. Traditional diagnostic methods rely on clinical signs and symptoms, which have limitations. Global preeclampsia diagnostics market can witness growth due to increasing awareness about the condition. Various new diagnostic tools are being developed and adopted to screen women at risk and enable timely identification of the disorder.
Market Dynamics:
Global preeclampsia diagnostics market growth is driven by growing incidence of preeclampsia worldwide. According to recent estimates, preeclampsia complicates around 5-8% of all pregnancies globally. Rising maternal age of first-time mothers can contribute to its rising caseload. New product launches and increasing adoption of advanced diagnostic technologies for early screening can offer opportunities for market growth. However, limited awareness about preeclampsia in low income regions and lack of universal healthcare can hamper the market growth. High cost of new diagnostic devices can pose challenge, especially in price-sensitive developing markets.
Key Features of the Study:
- This report provides in-depth analysis of the global preeclampsia diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global preeclampsia diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Roche, Thermo Fischer Scientific, Bayer, Siemens Healthineers, DRG Instruments GmbH
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global preeclampsia diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preeclampsia diagnostics market
Detailed Segmentation-
- By Test Type
- Blood Tests
- Urine Analysis
- Others
- By Product Type
- Instruments
- Consumables
- By End User
- Hospital
- Specialty Clinics
- Diagnostic Centers
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Roche Diagnostic
- Thermo Fisher Giving Inc.
- PerkinElmer
- Siemens Healthineers
- Abbott Laboratories
- Beckman Coulter
- Becton, Dickinson and Company (BD)
- bioMerieux
- Hoffmann-La Roche Ltd
- Metabolomic Diagnostics Ltd
- Diabetomics, Inc.
- Quidel Corporation
- Sera Prognostics
- Brahms GmbH
- The Progenix GrouP
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Preeclampsia Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Preeclampsia Diagnostics Market, By Test Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Blood Tests
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Urine Analysis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Preeclampsia Diagnostics Market, By Product Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Preeclampsia Diagnostics Market, By End User, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Preeclampsia Diagnostics Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Roche Diagnostic
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Giving Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PerkinElmer
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Siemens Healthineers
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott Laboratories
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Beckman Coulter
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Becton, Dickinson and Company (BD)
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- bioMerieux
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Metabolomic Diagnostics Ltd
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Diabetomics, Inc.
- Quidel Corporation
- Sera Prognostics
- Brahms GmbH
- The Progenix Group
- Roche Diagnostic
10. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
